Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Raskas Daniel | SVP - Corporate Development | Jul 25 '24 | Sale | 270.51 | 14,507 | 3,924,352 | 23,595 | Jul 26 05:03 PM | | Ellis Brian W | Senior Vice President - GC | Jul 25 '24 | Sale | 275.16 | 9,600 | 2,641,536 | 20,230 | Jul 26 05:03 PM | | SCHWIETERS JOHN T | Director | Jul 15 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 19,808 | Jul 16 05:00 PM | | Zerhouni Elias A. | Director | Jul 15 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 37,483 | Jul 16 05:01 PM | | Blair Rainer | President & CEO | May 16 '24 | Sale | 265.00 | 9,005 | 2,386,325 | 106,990 | May 17 05:08 PM | | King William | SVP, Strategic Development | May 15 '24 | Option Exercise | 50.37 | 12,623 | 635,821 | 55,208 | May 17 05:10 PM | | Blair Rainer | President & CEO | May 14 '24 | Option Exercise | 59.91 | 19,085 | 1,143,435 | 135,080 | May 15 05:00 PM | | Blair Rainer | President & CEO | May 14 '24 | Sale | 255.00 | 19,085 | 4,866,675 | 115,995 | May 15 05:00 PM | | McGrew Matthew | EVP & Chief Financial Officer | May 10 '24 | Option Exercise | 61.25 | 25,174 | 1,541,794 | 45,338 | May 13 05:01 PM | | McGrew Matthew | EVP & Chief Financial Officer | May 10 '24 | Sale | 253.05 | 46,377 | 11,735,856 | 29,407 | May 13 05:01 PM | | SPOON ALAN G | Director | May 02 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 116,910 | May 03 05:03 PM | | SPOON ALAN G | Director | May 02 '24 | Sale | 243.58 | 708 | 172,455 | 116,202 | May 03 05:03 PM | | Weidemanis Joakim | Executive Vice President | Apr 25 '24 | Option Exercise | 58.48 | 22,433 | 1,311,882 | 112,845 | Apr 26 05:00 PM | | Weidemanis Joakim | Executive Vice President | Apr 25 '24 | Sale | 250.46 | 22,433 | 5,618,569 | 90,412 | Apr 26 05:00 PM | | Blair Rainer | President & CEO | Apr 24 '24 | Option Exercise | 59.91 | 38,170 | 2,286,870 | 154,165 | Apr 25 05:00 PM | | Blair Rainer | President & CEO | Apr 24 '24 | Sale | 249.22 | 47,175 | 11,756,725 | 115,995 | Apr 25 05:00 PM | | Ellis Brian W | Senior Vice President - GC | Apr 24 '24 | Sale | 250.01 | 4,000 | 1,000,040 | 29,830 | Apr 25 05:00 PM | | Raskas Daniel | SVP - Corporate Development | Feb 26 '24 | Option Exercise | 58.48 | 23,757 | 1,389,309 | 61,859 | Feb 27 05:01 PM | | Raskas Daniel | SVP - Corporate Development | Feb 26 '24 | Sale | 252.00 | 23,757 | 5,986,764 | 38,102 | Feb 27 05:01 PM | | LOHR WALTER G | Director | Feb 15 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 17,418 | Feb 16 05:01 PM | | LOHR WALTER G | Director | Feb 15 '24 | Sale | 251.15 | 3,289 | 826,032 | 14,129 | Feb 16 05:01 PM | | Couchara Georgeann | SVP, Human Resources | Feb 13 '24 | Option Exercise | 70.71 | 2,622 | 185,414 | 6,022 | Feb 14 05:00 PM | | Couchara Georgeann | SVP, Human Resources | Feb 13 '24 | Sale | 242.67 | 2,622 | 636,290 | 4,244 | Feb 14 05:00 PM | | List Teri | Director | Feb 06 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 23,015 | Feb 08 05:00 PM | | List Teri | Director | Feb 06 '24 | Sale | 248.32 | 3,289 | 816,724 | 19,726 | Feb 08 05:00 PM | | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | Aug 21 '23 | Sale | 250.54 | 590 | 147,819 | 6,939 | Aug 22 05:00 PM | | Raskas Daniel | SVP - Corporate Development | Jul 28 '23 | Option Exercise | 56.70 | 11,213 | 635,777 | 49,501 | Aug 01 05:03 PM | | Zerhouni Elias A. | Director | Jul 28 '23 | Option Exercise | 50.80 | 3,490 | 177,292 | 30,523 | Aug 01 05:02 PM | | SCHWIETERS JOHN T | Director | Jul 28 '23 | Option Exercise | 50.80 | 3,490 | 177,292 | 22,583 | Aug 01 05:02 PM | | FILLER LINDA | Director | Jul 28 '23 | Option Exercise | 59.17 | 2,922 | 172,895 | 41,074 | Aug 01 05:00 PM | | Raskas Daniel | SVP - Corporate Development | Jul 28 '23 | Sale | 260.65 | 11,213 | 2,922,652 | 38,288 | Aug 01 05:03 PM | | FILLER LINDA | Director | Jul 28 '23 | Sale | 260.25 | 10,190 | 2,651,978 | 38,152 | Aug 01 05:00 PM |
|
